Former Eli Lilly Boss Awarded for Outstanding Contribution in the BioPharmaChem Sector

Biopharmachem Ireland, the Ibec group representing the biopharma and chemical sectors, has awarded former Executive Director of Eli Lilly, Eamon Judge, with their Outstanding Achievement Award. He received this accolade at a gala dinner hosted at Fota, Cork. Eamon recently retired from his role as Executive Director at Eli Lilly's Global Engineering Headquarters after a 43-year career in the biopharma industry.

During his career, Eamon represented Lilly on the governance council of BiopharmaChem Ireland and contributed to the development of one of the first BPCI Strategic Plans for the biopharma sector. He subsequently served as President for two terms of the Ireland Affiliate of the International Society for Pharmaceutical Engineering, as well as Chairing the European Affiliate Council of ISPE. He also founded and led the COVID Alliance, a pan-industry, academia, and state agency response in support of the HSE during the pandemic.

In accepting the award, Eamon Judge said:

"I am very honoured to accept this recognition from my colleagues and friends in the Irish biopharma sector. Over the past 4 decades I have seen the sector thrive and develop the skills and capabilities to establish Ireland as a preeminent global hub for lifesciences. The collaboration that I have witnessed between the commercial, academic and state sectors in Ireland is unique globally and is key to the sector's future success. Millions of patients around the world have benefited from the immense talents of the team members and leadership of the biopharma sites all over Ireland. I would especially like to say a sincere thank you to my former colleagues in Lilly Kinsale who have been so pivotal in assisting me and my family during my career."

Brian Killen, Digital Transformation Lead at MSD Manufacturing and Chair of BioPharmaChem Ireland, said:

“During his career, Eamon represented Lilly on the governance council of BiopharmaChem Ireland and contributed to the development of one of the first BPCI Strategic Plans for the biopharma sector. He subsequently served as President for two terms of the Ireland Affiliate of the International Society for Pharmaceutical Engineering, as well as Chairing the European Affiliate Council of ISPE. He also founded and led the COVID Alliance, a pan-industry, academia, and state agency response in support of the HSE during the pandemic.”

Dr. Sinead Keogh, Director of BioPharmaChem, said:

"The Outstanding Contribution award is not only given to a leader who has led their business with distinction but to someone who has used their position to advance the sector in Ireland, have a positive impact on society, and contribute to the development of talent. Eamon epitomises these qualities, and our sector is all the better for the contributions he has made throughout his career."